Proton pump inhibitors do not reduce atazanavir concentrations in HIV-infected patients treated with ritonavir-boosted atazanavir

被引：17

作者：

Guiard-Schmid, JB ^{[1
]}

Poirier, JM

Bonnard, P

Meynard, JL

Slama, L

Lukiana, T

Jaillon, P

Pialoux, G

机构：

[1] Hop Tenon, Serv Malad Infect & Trop, F-75970 Paris, France

[2] Univ Paris 06, UFR St Antoine, Serv Pharmacol, F-75252 Paris, France

[3] Univ Paris 06, Hop St Antoine, Serv Malad Infect & Trop, F-75252 Paris, France

来源：

AIDS | 2005年 / 19卷 / 16期

关键词：

D O I：

10.1097/01.aids.0000189565.87600.4d

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1937 / 1938

页数：2

共 13 条

[1]

AGARWALA S, 2005, 12 C RETR OPP INF BO

[2]

ANTONIOU T, 2005, J ACQ IMMUN DEF SYND, V39, P123

[3]

ARGWALA S, 2005, 6 INT WORKSH CLIN PH

[4]

*EUR MED AG, 2004, 2026492004 EMEA

[5]

GIBBONS S, 2004, 7 INT C DRUG THER HI

[6] Importance of pH control in the management of GERD [J].

Hunt, RH .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (07) :649-657

[7] Lack of interaction between atazanavir and lansoprazole [J].

Kosel, BW ;

Storey, SS ;

Collier, AC .

AIDS, 2005, 19 (06) :637-638

[8]

KRUSE G, 2004, 52 INT WORKSH CLIN P

[9]

LUBER A, 2004, 7 INT C DRUG THER HI

[10] Simple and simultaneous determination of the HIV-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography [J].

Poirier, JM ;

Robidou, P ;

Jaillon, P .

THERAPEUTIC DRUG MONITORING, 2005, 27 (02) :186-192

← 1 2 →